April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Roles for Metalloproteinases in Remodeling of Corneal Stroma by Stem Cells
Author Affiliations & Notes
  • James L. Funderburgh
    Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • Richard P. Dannenberg
    Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • Mary M. Mann
    Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • Martha L. Funderburgh
    Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • Footnotes
    Commercial Relationships  James L. Funderburgh, None; Richard P. Dannenberg, None; Mary M. Mann, None; Martha L. Funderburgh, None
  • Footnotes
    Support  NEI Grants EY016415, EY09368, and P30-EY08098; Research to Prevent Blindness, Eye and Ear Foundation of Pittsburgh
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3946. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      James L. Funderburgh, Richard P. Dannenberg, Mary M. Mann, Martha L. Funderburgh; Roles for Metalloproteinases in Remodeling of Corneal Stroma by Stem Cells. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3946.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Adult corneal stroma stem cells remodel stromal extracellular matrix (ECM) in vivo, restoring transparency to lumican knockout mice (Stem Cells 27:1635). This study tests the hypothesis that remodeling by stem cells requires action of specific matrix metalloproteinases (MMPs) by stem cells and that these differ from the MMPs active during wound healing.

Methods: : Human corneal stromal stem cells (CSSC) isolated from donor corneas were cultured on collagen substrata in medium inducing differentiation to keratocytes. MMP expression was detected by quantitative RT-PCR and by digestion of fluorescent collagen substrata in the presence of MMP inhibitors. Keratan sulfate expression was detected using immunoblotting and mRNA expression of keratocyte markers examined by qPCR. Cell migration through collagen-coated transwell filters was examined in presence of MMP inhibitors.

Results: : Culture of CSSC on collagen gels or injection into mouse cornea induced expression of mRNA for MMPs 1,2,3,11 and 14. Corneal fibroblasts representing a model of wound healing cells, expressed much higher levels of MMP2 and MMP16 and less MMP11 than the CSSC. Induction of differentiation of CSSC resulted in a rapid degradation of fluorescent collagen substrata. This phenomenon was blocked by MMP inhibitor GM6001 and by antibodies or siRNA blocking MMP14 (MT1-MMP). Expression of keratan sulfate and the mRNA for keratan sulfate biosynthetic enzymes (B3GNT7, CHST6) was reduced by inhibition of MMP action with GM6001 as was the migration of keratocytes in a transwell assay.

Conclusions: : To remodel disorganized stroma, restoring transparency, CSSC need to first remove existing collagenous ECM. These results indicate that in response to collagenous environment, a spectrum of MMPs is induced that is distinct from that of wound-healing fibroblasts. Digestion of the ECM is dependent on expression of the cell-associated MMP14. MMP action also appears to be necessary for CSSC to migrate through a collagen matrix and to synthesize the characteristic corneal glycosaminoglycan, keratan sulfate.

Keywords: cornea: stroma and keratocytes • extracellular matrix • enzymes/enzyme inhibitors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×